Research Investment for Global Health Technology Foundation
Tracked across 1 events · 6 articles · First seen Jun 09, 2026 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Altor BioScience>>>, a global vaccine and biotech company, has entered into a license agreement with the United States — Centers for Disease Control and Prevention>>> (CDC) to develop an injectable rotavirus vaccine candidate. This marks…
Impact: The Research Investment for Global Health Technology Foundation>>> is co-investing with Altor BioScience>>> to support the process development of the rotavirus vaccine, aiming to reduce infectious disease burden in low- and middle-income countries.
Jun 09, 2026 · 6 articles
75
Altor BioScience signed funding agreement Research Investment for Global Health Technology FoundationSK_bioscience licenses CDC...
60
Research Investment for Global Health Technology Foundation provides official development assistanceSK_bioscience licenses CDC...
NEWSDESK
Track Research Investment for Global Health Technology Foundation live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard